Background: Despite global concerns of an opioid epidemic, there is no systematic literature review on how frequently these drugs are used in nursing home (NH) populations, including those living with dementia. Objective: This systematic review aims to describe the prevalence and incidence of opioid use in NHs. A secondary objective is to describe the use of these drugs in a subset of NH residents, namely among persons living with dementia. Methods: A systematic literature review was carried out using MEDLINE and Scopus (PROSPERO registration number CRD42021254210). Screening of title and abstract was carried out by 2 persons independently for studies published between January 1, 2011 and May 19, 2021. The main outcomes were annual prevalence, period prevalence, and duration of opioid use. Results: From a total of 178 identified studies, 29 were considered eligible for inclusion. The annual prevalence of any opioid use among all NH residents without any selection criteria ranged from 6.3% to 50% with a median annual prevalence of 22.9% (Q25-Q75: 19.5%-30.2%), based on 17 studies. Five studies measured the annual prevalence in NH residents living with dementia, finding that this ranged from 10% to 39.6%. Conclusions: More evidence is needed quantifying opioid use in NH, especially among persons living with dementia. Given that opioid use in NH is still a problem, implementation of a pain management protocol in NH or nationally would help improve clinical outcomes.
NobleMTreadwellJRTregearSJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1:CD006605.
2.
GilsonAMMaurerMARyanKMSkemp-BrownMHusainAClearyJF. Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy. J Pain Palliat Care Pharmacother. 2011;25(3):246-251.
3.
VolkowNDKoroshetzWJ. The role of neurologists in tackling the opioid epidemic. Nat Rev Neurol. 2019;15(5):301-305.
4.
BlendonRJBensonJM. The public and the opioid-abuse epidemic. N Engl J Med. 2018;378(5):407-411.
5.
WuL-TBlazerDG. Illicit and nonmedical drug use among older adults: a review. J Aging Health. 2011;23(3):481-504.
6.
ShoffCYangT-CShawBA. Trends in opioid use disorder among older adults: analyzing medicare data, 2013–2018. Am J Prev Med. 2021;60(6):850-855.
7.
BelzakLHalversonJ. The opioid crisis in Canada: a national perspective. Health Promot Chronic Dis Prev Can. 2018;38(6):224-233.
8.
VerhammeKMCBohnenAM. Are we facing an opioid crisis in Europe?Lancet Public Health. 2019;4(10):e483-e484.
9.
KimberJHickmanMStrangJThomasKHutchinsonS. Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis. Lancet Psychiatry. 2019;6(8):639-640.
10.
DesaiRJHernandez-DiazSBatemanBTHuybrechtsKF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997-1002.
11.
DesaiRJHuybrechtsKFHernandez-DiazS, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350:h2102.
12.
BatemanBTHernandez-DiazSRathmellJP, et al. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology. 2014;120(5):1216-1224.
13.
MoyoPZhaoXThorpeCT, et al. Dual receipt of prescription opioids from the Department of Veterans Affairs and Medicare Part D and prescription opioid overdose death among veterans: a nested case-control study. Ann Intern Med. 2019;170(7):433-442.
14.
RolandCLYeXStevensVOderdaGM. The prevalence and cost of Medicare beneficiaries diagnosed and at risk for opioid abuse, dependence, and poisoning. J Manag Care Spec Pharm. 2019;25(1):18-27.
15.
JefferyMMHootenWMHenkHJ, et al. Trends in opioid use in commercially insured and Medicare advantage populations in 2007-16: retrospective cohort study. BMJ. 2018;362:k2833. Erratum in: BMJ. 2018;363:k4825. doi:10.1136/bmj.k2833
16.
DaoustRPaquetJMooreL, et al. Incidence and risk factors of long-term opioid use in elderly trauma patients. Ann Surg. 2018;268(6):985-991.
17.
GomesTJuurlinkDNAntoniouT, et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396.
18.
LewerDPadmanathanPQummerUlArfeenM, et al. Healthcare use by people who use illicit opioids (HUPIO): development of a cohort based on electronic primary care records in England. Wellcome Open Res. 2020;5:282.
19.
WeesieYMHekKSchermerTRJ, et al. Use of opioids increases with age in older adults: an observational study (2005-2017). Front Pharmacol. 2020;11:648.
20.
KalkmanGAKramersCvan DongenRTvan den BrinkWSchellekensA. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health. 2019;4(10):e498-e505.
21.
IngrasciottaYSultanaJGiorgianniF, et al. Analgesic drug use in elderly persons: a population-based study in Southern Italy. PLoS ONE. 2019;14(9):e0222836.
22.
BarberNDAlldredDPRaynorDK, et al. Care homes’ use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. BMJ Qual Saf. 2009;18:341-346.
23.
HemmingssonESGustafssonMIsakssonU, et al. Prevalence of pain and pharmacological pain treatment among old people in nursing homes in 2007 and 2013. Eur J Clin Pharmacol. 2018;74(4):483-488.
24.
HuseboB SBallardCSandvikRNilsenO BAarslandD.Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:d4065.
25.
HunnicuttJNChrysanthopoulouSAUlbrichtCMHumeALTjiaJLapaneKL. Prevalence of long-term opioid use in long-stay nursing home residents. J Am Geriatr Soc. 2018;66(1):48-55.
26.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
27.
MehtaHBKuoYFRajiMLiSWestraJGoodwinJS. Time trends in opioid use by dementia severity in long-term care nursing home residents. J Am Med Dir Assoc. 2021;22(1):124-131.e1.
28.
GustafssonMLämåsKIsakssonUSandmanPOLövheimH. Constipation and laxative use among people living in nursing homes in 2007 and 2013. BMC Geriatr. 2019;19(1):38.
29.
FogAFStraandJEngedalKBlixHS. Drug use differs by care level: a cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway. BMC Geriatr. 2019;19(1):49.
30.
Kalisch EllettLMKassieGMPrattNLKerrMRougheadEE. Prevalence and duration of use of medicines recommended for short-term use in aged care facility residents. Pharmacy (Basel). 2019;7(2):55.
31.
PimentelCBGurwitzJHTjiaJHumeALLapaneKL. New initiation of long-acting opioids in long-stay nursing home residents. J Am Geriatr Soc. 2016;64(9):1772-8.
32.
Jensen-DahmCZakariasJKGasseCWaldemarG. Geographical variation in opioid use in elderly patients with dementia: a nationwide study. J Alzheimers Dis. 2019;70(4):1209-1216.
33.
LandiFLattanzioFDell’AquilaG, et al. Prevalence and potentially reversible factors associated with anorexia among older nursing home residents: results from the ULISSE project. J Am Med Dir Assoc. 2013;14(2):119-24.
34.
FainKMAlexanderGCDoreDDSegalJBZulloARCastillo-SalgadoC. Frequency and predictors of analgesic prescribing in U.S. nursing home residents with persistent pain. J Am Geriatr Soc. 2017;65(2):286-293.
35.
BrennanPLSooHooS. Psychiatric disorders and pain treatment in community nursing homes. Am J Geriatr Psychiatry. 2014;22(8):792-800.
36.
PitkalaKHJuolaALHosiaH, et al. Eight-year trends in the use of opioids, other analgesics, and psychotropic medications among institutionalized older people in Finland. J Am Med Dir Assoc. 2015;16(11):973-978.
37.
Jensen-DahmCGasseCAstrupAMortensenPBWaldemarG. Frequent use of opioids in patients with dementia and nursing home residents: a study of the entire elderly population of Denmark. Alzheimers Dement. 2015;11(6):691-699.
38.
NunziataVProiettiMSaporitiE, et al. Pain management in nursing home residents: results from the INCUR study. J Nutr Health Aging. 2020;24(9):1019-1022.
39.
RoittoHMKautiainenHAaltoULÖhmanHLaurilaJPitkäläKH. Fourteen-year trends in the use of psychotropic medications, opioids, and other sedatives among institutionalized older people in Helsinki, Finland. J Am Med Dir Assoc. 2019;20(3):305-311.
40.
Al-JumailiAADoucetteWR. A systems approach to identify factors influencing adverse drug events in nursing homes. J Am Geriatr Soc. 2018;66(7):1420-1427.
41.
WeiYJSchmidtSChenC, et al. Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia. Alzheimers Res Ther. 2021;13(1):78.
42.
KrügerKFolkestadMGeitungJTEideGEGrimsmoA. Psychoactive drugs in seven nursing homes. Prim Health Care Res Dev. 2012;13(3):244-254.
43.
TanECVisvanathanRHilmerSN, et al. Analgesic use and daytime sleepiness in residents with and without dementia in residential aged care facilities. Drugs Aging. 2015;32(12):1045-1053.
44.
TanECVisvanathanRHilmerSN, et al. Analgesic use and pain in residents with and without dementia in aged care facilities: a cross-sectional study. Australas J Ageing. 2016;35(3):180-187.
45.
RabanMZBaysariMTJorgensenMLTariqAGeorgiouAWestbrookJI. Unmet needs for transdermal patch management in electronic medication administration records: an analysis of data from 66 aged care facilities. Appl Clin Inform. 2020;11(5):812-820.
46.
JobskiKBantelCHoffmannF. Utilization of transdermal fentanyl in German nursing home residents from 2010 to 2014. Pharmacoepidemiol Drug Saf. 2019;28(5):754-759.
47.
Neumann-PodczaskaANowakTSuwalskaA, et al. Analgesic use among nursing homes residents, with and without dementia, in Poland. Clin Interv Aging. 2016;11:335-340.
48.
GadzhanovaSRougheadEEPontLG. Safety of opioid patch initiation in Australian residential aged care. Med J Aust. 2015;203(7):298.
49.
GriffioenCHuseboBSFloECaljouwMAAAchterbergWP. Opioid prescription use in nursing home residents with advanced dementia. Pain Med. 2019;20(1):50-57.
50.
ErsekMNashPVHilgemanMM, et al. Pain patterns and treatment among nursing home residents with moderate-severe cognitive impairment. J Am Geriatr Soc. 2020;68(4):794-802.
51.
BarryHEParsonsCPassmoreAPHughesCM. Pain in care home residents with dementia: an exploration of frequency, prescribing and relatives’ perspectives. Int J Geriatr Psychiatry. 2015;30(1):55-63.
52.
van der MaadenTvan der SteenJTde VetHCHertoghCMKoopmansRT. Prospective observations of discomfort, pain, and dyspnea in nursing home residents with dementia and pneumonia. J Am Med Dir Assoc. 2016;17(2):128-135.
53.
JassalMEganGDahriK. Opioid prescribing in the elderly: a systematic review. J Pharm Technol. 2020;36(1):28-40.
54.
MareeRDMarcumZASaghafiEWeinerDKKarpJF. A systematic review of opioid and benzodiazepine misuse in older adults. Am J Geriatr Psychiatry. 2016;24(11):949-963.
55.
YoshikawaARamirezGSmithML, et al. Opioid use and the risk of falls, fall injuries and fractures among older adults: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2020;75(10):1989-1995.
56.
CrushJLevyNKnaggsRDLoboDN. Misappropriation of the 1986 WHO analgesic ladder: the pitfalls of labelling opioids as weak or strong. Br J Anaesth. 2022:129(2):137-142.
57.
ChouRTurnerJADevineEB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276-86.
58.
ShenYBhagwandassHBranchcombT, et al. Chronic opioid therapy: a scoping literature review on evolving clinical and scientific definitions. J Pain. 2021;22(3):246-262.
59.
Hincapie-CastilloJMGoodinAPossingerMCUsmaniSAVouriSM. Changes in opioid use after Florida’s restriction law for acute pain prescriptions. JAMA Netw Open. 2020;3(2):e200234.
60.
DaveCVPatornoEFranklinJM, et al. Impact of state laws restricting opioid duration on characteristics of new opioid prescriptions. J Gen Intern Med. 2019;34(11):2339-2341.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
